Inventor
VEVERKA KAREN A
US15 patents
⚠️ This page may combine multiple inventors who share the name “VEVERKA KAREN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV TENNESSEE RES FOUNDATION
10 patentsUS7026500B2Apr 11, 2006
Halogenated selective androgen receptor modulators and methods of use thereof
UNIV TENNESSEE RES FOUNDATION109 citations98
US6838484B2Jan 4, 2005
Formulations comprising selective androgen receptor modulators
UNIV TENNESSEE RES FOUNDATION137 citations98
US8008348B2Aug 30, 2011
Treating muscle wasting with selective androgen receptor modulators
UNIV TENNESSEE RES FOUNDATION31 citations92
US7855229B2Dec 21, 2010
Treating wasting disorders with selective androgen receptor modulators
UNIV TENNESSEE RES FOUNDATION20 citations92
US7705182B2Apr 27, 2010
Multi-substituted selective androgen receptor modulators and methods of use thereof
UNIV TENNESSEE RES FOUNDATION28 citations92
US7622503B2Nov 24, 2009
Selective androgen receptor modulators and methods of use thereof
UNIV TENNESSEE RES FOUNDATION36 citations92
US7547728B2Jun 16, 2009
Treating muscle wasting with selective androgen receptor modulators
UNIV TENNESSEE RES FOUNDATION40 citations92
US7803970B2Sep 28, 2010
Multi-substitued selective androgen receptor modulators and methods of use thereof
UNIV TENNESSEE RES FOUNDATION19 citations84
US7776921B2Aug 17, 2010
Treating benign prostate hyperplasia with SARMS
UNIV TENNESSEE RES FOUNDATION11 citations83
US7968721B2Jun 28, 2011
Large-scale synthesis of selective androgen receptor modulators
UNIV TENNESSEE RES FOUNDATION0 citations34
GTX INC
4 patentsUS8003689B2Aug 23, 2011
Metabolites of selective androgen receptor modulators and methods of use thereof
GTX INC48 citations97
US6899888B2May 31, 2005
Prevention and treatment of androgen-deprivation induced osteoporosis
GTX INC52 citations96
US7595402B2Sep 29, 2009
Prodrugs of selective androgen receptor modulators and methods of use thereof
GTX INC9 citations84
US7524866B2Apr 28, 2009
Prevention and treatment of androgen—deprivation induced osteoporosis
GTX INC3 citations62